Send us Feedback

Exactech (EXAC)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Exactech, Inc. (EXAC) Tops Q1 EPS by 1c
StreetInsider.com  May 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Exactech%2C+Inc.+%28EXAC%29+Tops+Q1+EPS+by+1c/7390440.html for the full story.
Exactech Q1 Revenue Up 10% to $58.6 Million, Net Income $3.3 Million, Diluted EPS $0.25
Business Wire  May 1  Comment 
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $58.6 million for the first quarter of 2012, a 10% increase over $53.4
Exactech Schedules First Quarter 2012 Earnings Release and Conference Call
Business Wire  Apr 17  Comment 
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its first quarter 2012 financial results on Tuesday, May 1, 2012. A copy of the
Exactech Announces Expiration of Deferred Prosecution Agreement
Benzinga  Mar 15  Comment 
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the Deferred Prosecution Agreement entered into effective December 7, 2010...
Exactech 2011 Revenue Up 8% to $205M; Net Income $8.8M, EPS $0.67; Q4 Net Income $1.8M, EPS $0.14
Business Wire  Feb 28  Comment 
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, announced today that revenue for 2011 increased 8% to $205.4 million from $190.5 million in 2010.
Exactech Announces $100 Million Long Term Syndicated Credit Facility
Business Wire  Feb 27  Comment 
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced that it has entered into a $100 million Credit Agreement with a syndicate of banks
Exactech, Inc. (EXAC) Enters Into $100 Million Credit Agreement
StreetInsider.com  Feb 27  Comment 
Exactech, Inc. (EXAC) Reports In-Line Q2 EPS and Revenue
StreetInsider.com  Aug 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Exactech%2C+Inc.+%28EXAC%29+Reports+In-Line+Q2+EPS+and+Revenue/6678696.html for the full story.
Exactech (EXAC) Settles with USAO; To Pay $2.99M, Must Meet Certain Obligations
StreetInsider.com  Dec 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Exactech+%28EXAC%29+Settles+with+USAO%3B+To+Pay+%242.99M%2C+Must+Meet+Certain+Obligations/6149068.html for the full story.
Exactech Q3 Revenue $42.0M; EPS $0.11 Market Leading Extremity Growth at 33%
Benzinga  Nov 2  Comment 
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $42.0 million for the third quarter of 2010, a 1% decrease from $42.4...
Exactech (EXAC) Misses Q3 EPS by 9c; Issues Mixed Guidance
StreetInsider.com  Nov 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Exactech+%28EXAC%29+Misses+Q3+EPS+by+9c%3B+Issues+Mixed+Guidance/6069838.html for the full story.




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Exactech_(EXAC)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki